CAV1 and neoplasm: For example, reduced stromal expression of cav-1 has been associated with a poor prognosis [9, 10], decreased disease-free survival [11], tumor invasiveness [11], lymph node metastases [10], and hormone receptor status [10] in patients with breast cancer.